Altium Capital Management LP Arrowhead Pharmaceuticals, Inc. Transaction History
Altium Capital Management LP
- $301 Million
- Q4 2024
A detailed history of Altium Capital Management LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Altium Capital Management LP holds 230,257 shares of ARWR stock, worth $4.4 Million. This represents 1.44% of its overall portfolio holdings.
Number of Shares
230,257
Previous 355,000
35.14%
Holding current value
$4.4 Million
Previous $6.87 Million
37.02%
% of portfolio
1.44%
Previous 2.42%
Shares
2 transactions
Others Institutions Holding ARWR
# of Institutions
298Shares Held
91.8MCall Options Held
199KPut Options Held
453K-
Black Rock Inc. New York, NY15.7MShares$300 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$233 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$170 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$121 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$93.4 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.02B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...